Kuros Biosciences

Provider of smart solutions for bone disease management

placeSchlieren, Zurich, Switzerland calendar_todayFounded 2000 groups66 employees language kurosbio.com

Registered entities

Innovation

11 patent families (9 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 1,922 times.

YearFilings
20132
20164
20173
20186
20192
20203
20221
20251

Social engagement

Social engagement: 13.5K social following, 1 post in the last 12 months — around the industry typical range.

Investor mix

14 investors on record; lead investors include NeoMed, DEFI Gestion, VI Partners, Renaissance; 2 have since exited.

Investor typeCountShare
Venture capital536%
Private equity321%
Other / undisclosed643%

Recent activity

17 Jun 2026
Event
Capital Markets Day
Coming soon